Pathological Conditions, Signs and Symptoms

144 trials 75 recruiting

Filter these 144 trials by phase, country and sponsor.

Open in Search →

COMBINATORY IMMUNOTHERAPY-2 (COM-IT-2) A phase 2 randomised open two-arm study to assess the tolerability and efficacy of immunotherapy comb… Recruiting

2023-510089-28-00 Non-small cell lung cancer (Stage IV) 9 2024-05-22
Akynzeo as antiemetic treatment in patients with endometrial cancer treated with taxane - platinum combination chemotherapy. NOEME study. Recruiting

2023-504150-35-00 Endometrial cancer 6 2024-02-21
EDULOX 2- Patientundervisning og medicinsk behandling (duloxetin/aktiv placebo) til patienter med svær funktionel lidelse: et randomiseret, … Recruiting

2024-514264-42-00 Functional Somatic disorder 6 2024-02-09
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis: A multicenter, randomized placebo controlled and biological endpoints clinical… Recruiting

2024-518888-35-00 amyotrophic lateral sclerosis patients 4 2024-01-24
A multi-centre, open, prospective, randomized, parallel-group, 24-month study to compare the outcome of receiving continued immunosuppressio… Recruiting

2023-506879-98-00 Renal transplantation 6 2024-01-22
First in human clinical trial to evaluate the safety, tolerability and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in pat… Recruiting

2022-503084-15-00 Progressive metastatic solid cancer after failure of es 1 2024-01-12
Early Initiated Vasopressor Therapy in the Emergency Department - A Multi-center Randomized Controlled Trial (VASOSHOCK) Recruiting

2023-504584-16-00 Hypotension 5 2023-12-08
Phase 3 confirmatory, randomised 1:1 double-blind, placebo-controlled study evaluating the analgesic efficacy of capsaicin 8% patches in chr… Recruiting

2023-504644-34-00 Subject with chronic coccygodynia 5 2023-11-08
INduction in Sensitized kidney Transplant recipients without pre-Existing donor-specific AntiboDies: a randomized multicentre trial between … Recruiting

2022-502007-30-00 Kidney transplant 5 2023-11-07
TransNiDeG Recruiting

2023-503349-71-00 Pancreatodudoenectomy 4 2023-10-30
Capsaicin 179 mg patch versus oral Duloxetine in patients with chemotherapy-induced peripheral neuropathy: a phase 3 randomized multicentric… Recruiting

2023-504618-31-00 Chemotherapy induced peripheral neuropathy (CIPN) 5 2023-10-20
The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury (KETA-BID) Recruiting

2024-515315-22-00 subarachnoid hemorrhage, intracerebral hemorrhage, trau 6 2023-09-15
Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology. Recruiting

2022-500933-10-00 Preeclampsia during pregnancy 11 2023-08-02
Desflurane versus Sevoflurane versus Propofol on postoperative delirium in elderly patients Recruiting

2023-503717-30-00 Elderly patients undergoing moderate- to high-risk majo 11 2023-07-19
HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod… Recruiting

2023-504661-23-00 Antiphospholipid antibodies 5 2023-06-27
Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of Sodium Zirconium Cyclosilicate (Lokelma) compared to s… Recruiting

2024-517631-43-00 Hyperkalemia in patients with chronic kidney disease 5 2022-12-12
Randomized clinical trial to evaluate the utility of CYP2D6 genotyping to improve the efficacy and safety of tramadol in the treatment of ac… Recruiting

2022-500377-13-01 Pharmakogenetics 6 2022-10-05
NeoAdjuvant PErsonalized therapy in Estrogen Receptor positive breast cancer (NAPEER) - An open label phase II trial of endocrine treatment… Recruiting

2023-510093-13-00 Patients with hormone receptor positive HER2 negative b 4 2022-05-11
Early rituximab treatment in children with idiopathic nephrotic syndrome Eng. ERICONS - Early RITUXIMAB in Childhood Onset Nephrotic Syndrom… Recruiting

2024-515058-26-00 NEPHROTIC SYNDROME 5 2021-12-17
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. Recruiting

2023-505497-14-00 Proteinuric glomerular diseases including: •Focal segm 4 2021-12-09
Short-term Pre-OPerative Durvalumab (MEDI 4736) in early small triple negative breast cancer patients (POP-Durva) Recruiting

2024-512082-14-00 Untreated small triple negative breast cancer 4 2021-12-06
Felzartamab in late ABMR Recruiting

2024-511764-86-00 late antibody mediated renal transplant rejection 4 2021-09-07
Personalized therapy of metastatic thyroid cancer: biological characterization and optimization with 124I PET dosimetry Recruiting

2024-516273-80-00 Metastatic DTC 4 2021-05-12
Goal directed fluid removal in critically ill patients with fluid overload Recruiting

2024-512186-14-00 Fluid overload/fluid accumulation 6 2020-08-24